Co-diagnostics, inc. to host booth at eccmid 2022 in lisbon, portugal on april 23-26

Salt lake city , april 22, 2022 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the upcoming 32nd european congress of clinical microbiology & infectious diseases (eccmid), held april 23-26, 2022, in lisbon, portugal. the congress, which brings together experts from clinical microbiology and infectious disease fields to present their latest findings, guidelines and experiences to an audience of over 14,000 colleagues, will also feature a hybrid format for the first time, to facilitate an onsite and online experience for attendees allowing for remote and face-to-face opportunities.
CODX Ratings Summary
CODX Quant Ranking